EADV 2025 Congress

ADVENT at EADV 2025: Join Sanofi and Regeneron for three educational symposia on BP, CSU, and AD.

Remind me

17 - 20Sept2025

Begins in

57days

1hour

Location

Paris Expo Porte de Versailles

1 Pl. de la Prte de Versailles 75015 Paris France

Symposium Details

September 17

Bullous Pemphigoid: Insights and Innovation

Experience this engaging presentation by Profs. Donna Culton, Dedee Murrell, and Ulrike Raap, who will highlight the heterogeneous clinical presentations of BP and its burden, delve beneath the surface into how autoimmunity and predominantly type 2 inflammation mediate the disease, and explore the evolving toolbox of current approaches in BP management.

September 19

The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of AD?

Join Profs. Jean-David Bouaziz, Amy Paller, and Alan Irvine for a dynamic presentation on the multifaceted burden of atopic dermatitis, the evolving concept of disease modification, and the how targeted systemic therapies may help improve long-term patient outcomes.

September 19

Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management

Experience this engaging presentation by Profs. Martin Metz, Elena Netchiporouk, and Jason Hawkes to explore emerging therapies for chronic spontaneous urticaria.

Location

Paris Expo Porte de Versailles

1 Pl. de la Prte de Versailles 75015 Paris France

Check on Google Maps

Tags

type 2 inflammation itch heterogeneity disease modification biomarkers coexisting diseases

MAT-GLB-2503793 - 1.0 - 07/2025

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: CanadaChange country/region